Welcome to our dedicated page for PACS Group SEC filings (Ticker: PACS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on PACS Group's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into PACS Group's regulatory disclosures and financial reporting.
PACS Group, Inc. President & COO Joshua Jergensen reported an open-market sale of common stock. On March 13, 2026, he sold 36,335 shares of PACS Group common stock at a weighted average price of $34.2823 per share.
The shares were sold in multiple trades at prices ranging from $34.28 to $34.3301 per share, according to the footnote. After these transactions, Jergensen directly owns 2,667,347 shares of PACS Group common stock.
PACS Group, Inc. director and executive officer Mark Hancock reported a bona fide gift transfer of 300,000 shares of common stock on March 5, 2026. The shares were gifted to a charitable donor-advised fund and carried a reported price of $0.00 per share. After this disposition, Hancock directly owned 54,504,443 shares of PACS Group common stock.
PACS Group, Inc. reported that director Patrick Hugh Conway acquired 3,497 restricted stock units (RSUs) of Common Stock as a grant. Each RSU represents the right to receive one share of Common Stock upon vesting. According to the terms, 100% of the RSUs will vest on the earlier of March 4, 2027 or the next annual meeting following the grant date, subject to his continued service to the company.
PACS Group, Inc. filed an initial insider ownership report for Patrick Hugh Conway, who is identified as a director of the company. This Form 3 filing establishes his status as a reporting person for future insider ownership and trading disclosures. The filing does not list any specific transactions.
PACS Group, Inc. has appointed Patrick H. Conway, MD, MSc, to its Board of Directors as a Class III director, with a term running until the 2027 annual stockholders’ meeting. He will receive the standard non-employee director compensation and sign the company’s usual indemnification agreement.
Dr. Conway is CEO of Optum, the health services business of UnitedHealth Group, and a former senior leader at the Centers for Medicare and Medicaid Services, where he helped drive the shift toward value-based care. The company highlights his clinical background as a practicing pediatric hospitalist and his national recognition for healthcare leadership.
The filing also notes that PACS operates more than 320 post-acute care facilities across 17 states, serves over 31,700 patients daily, and reported full-year 2025 revenue of $5.29 billion, a 29.3% year-over-year increase, underscoring its scale and recent growth in the skilled nursing sector.
PACS Group, Inc. reported that Chief Compliance Officer Kelly Priegnitz received an award of 30,000 shares of common stock in the form of restricted stock units. Each RSU converts into one share upon vesting. The RSUs vest in substantially equal annual installments on the first, second, and third anniversaries of December 1, 2025, contingent on continued service.
PACS Group, Inc. reported that Chief Human Resources Officer Trent Dean Bingham received a grant of 25,000 shares of Common Stock in the form of restricted stock units. Each RSU converts into one share upon vesting, in substantially equal annual installments on the first, second, and third anniversaries of November 10, 2025, contingent on continued service.
PACS Group, Inc. filed an initial ownership report on Form 3 for Kelly Priegnitz, who serves as Chief Compliance Officer. The filing establishes her status as an officer subject to insider reporting rules but does not list any specific transactions or share amounts.
PACS Group, Inc. executive Bingham Trent Dean, the company’s Chief Human Resources Officer, has filed an initial Form 3 reporting his status as an officer of the company. The filing does not report any insider buy, sell, acquisition, or disposal transactions in PACS Group stock.